GL64
GL64 is a selective agonist of ADGRD1 (EC50 = 3.98 μM) . GL64 has low selectivity for ADGRD2, ADGRG5, ADGRG6, CELSR1, CELSR2, CELSR3, and ADGRG4 isoforms. GL64 activates ADGRD1 by mimicking the satchel sequence. GL64 regulates osteoclast maturation through the cAMP-PKA-NFATC1 pathway. GL64 effectively inhibits osteoclastogenesis and prevents bone loss both in vitro and in vivo. GL64 is useful in the study of osteoclast-related diseases[1].
Product Specifications
CAS Number
488801-10-1
UNSPSC
12352005
Target
Endogenous Metabolite; Nuclear Factor of activated T Cells (NFAT)
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Field of Research
Endocrinology
Purity
98.80
Smiles
O=C1C2=CC=CC=C2NC(N1C3=CC=C(C=C3)Cl)C4=CC(OCC5=C(C=C(C=C5)Cl)Cl)=CC=C4
Molecular Formula
C27H19Cl3N2O2
Molecular Weight
509.81
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-IRF7 Antibody Picoband®, Dylight550 Conjugate
